Bausch Health Companies (BHC) Net Income - Minority (2013 - 2021)
Bausch Health Companies' (BHC) quarterly Net Income - Minority came in at -$76.0 million in Q2 2021, down 5.56% year-on-year from -$80.5 million in Q2 2020, and down 4.11% quarter-over-quarter from -$73.0 million in Q1 2021.
Bausch Health Companies (BHC) Net Income - Minority (2013 - 2021) Analysis & Trends
Bausch Health Companies has disclosed Net Income - Minority across 9 years of filings, most recently posting -$76.0 million for Q2 2021.
- Net Income - Minority for Q2 2021 came in at -$76.0 million, down 5.56% year-over-year; the trailing twelve-month figure through Jun 2021 was -$76.0 million (down 5.56% YoY), and the FY2020 annual result was -$70.0 million, up 4.11% from the prior year.
- Net Income - Minority came in at -$76.0 million for Q2 2021 at Bausch Health Companies, down from -$73.0 million in the prior quarter.
- In the past five years, Net Income - Minority ranged from a high of -$68.0 million in Q3 2020 to a low of -$101.0 million in Q1 2017.
- The 5-year median for Net Income - Minority is -$83.0 million (2018), against an average of -$83.3 million.
- Across the five-year window, Net Income - Minority gained 17.44% in 2020 and decreased 5.56% in 2021, its largest moves.
- Bausch Health Companies' Net Income - Minority stood at -$95.0 million in 2017, then grew by 13.68% to -$82.0 million in 2018, then climbed by 10.98% to -$73.0 million in 2019, then gained by 4.11% to -$70.0 million in 2020, then declined by 8.57% to -$76.0 million in 2021.
- The last three Net Income - Minority figures came in at -$76.0 million (Q2 2021), -$73.0 million (Q1 2021), and -$70.0 million (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -4.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -76.00 Mn |
| Mar 31, 2021 | -73.00 Mn |
| Dec 31, 2020 | -70.00 Mn |
| Sep 30, 2020 | -68.00 Mn |
| Jun 30, 2020 | -72.00 Mn |
| Mar 31, 2020 | -71.00 Mn |
| Dec 31, 2019 | -73.00 Mn |
| Sep 30, 2019 | -78.00 Mn |
| Jun 30, 2019 | -87.00 Mn |
| Mar 31, 2019 | -86.00 Mn |
| Dec 31, 2018 | -82.00 Mn |
| Sep 30, 2018 | -84.00 Mn |
| Jun 30, 2018 | -91.00 Mn |
| Mar 31, 2018 | -99.00 Mn |
| Dec 31, 2017 | -95.00 Mn |
| Sep 30, 2017 | -95.00 Mn |
| Jun 30, 2017 | -98.00 Mn |
| Mar 31, 2017 | -101.00 Mn |
| Dec 31, 2016 | -106.00 Mn |
| Sep 30, 2016 | -106.30 Mn |